Corvus Pharmaceuticals, Inc. (CRVS)
NASDAQ: CRVS · Real-Time Price · USD
14.36
+0.09 (0.63%)
Sep 2, 2026, 10:23 AM EDT - Market open
Corvus Pharmaceuticals Market Cap
Corvus Pharmaceuticals has a market cap or net worth of $1.21 billion as of September 2, 2026. Its market cap has increased by 182.44% in one year.
Market Cap
1.21B
Enterprise Value
993.48M
1-Year Change
182.44%
Ranking
Category
Stock Price
$14.36
ChartMarket Cap Chart
Since March 23, 2016, Corvus Pharmaceuticals's market cap has increased from $290.80M to $1.21B, an increase of 315.40%. That is a compound annual growth rate of 14.60%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 2, 2026 | 1.21B | 110.05% |
| Dec 31, 2025 | 575.10M | 67.28% |
| Dec 31, 2024 | 343.80M | 298.38% |
| Dec 29, 2023 | 86.30M | 117.93% |
| Dec 30, 2022 | 39.60M | -64.71% |
| Dec 31, 2021 | 112.20M | 12.31% |
| Dec 31, 2020 | 99.90M | -37.56% |
| Dec 31, 2019 | 160.00M | 48.84% |
| Dec 31, 2018 | 107.50M | -50.69% |
| Dec 29, 2017 | 218.00M | -27.09% |
| Dec 30, 2016 | 299.00M | 2.82% |
| Mar 23, 2016 | 290.80M | - |
View and export this data all the way back to 2016. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Immatics | 1.29B |
| Alpha Tau Medical | 1.29B |
| MoonLake Immunotherapeutics | 1.29B |
| MannKind | 1.28B |
| Seaport Therapeutics | 1.26B |
| Alumis | 1.23B |
| Monte Rosa Therapeutics | 1.22B |
| Odyssey Therapeutics | 1.17B |